A standardized approach is vital for the assessment of neuropathic cancer pain in order to improve treatment results and future clinical/pre-clinical studies.
All articles by Jessica Nye, PhD
Galcanezumab effectively treats episodic or chronic migraine after multiple standard of care preventive medication failures.
Patients with recent-onset sciatica who received early referral to physical therapy experienced better clinical outcomes compared with usual care.
Opioid products approved by the FDA between 1997 and 2018 relied on short- or intermediate-term studies that did not adequately analyze safety outcomes.
The number of Waddell signs present may indicate future treatment failure.
Adults with chronic back pain who had adverse allergic reactions to NSAIDs are at higher risk for developing an opioid use disorder.
Ascending and descending pain mechanisms may be associated with Knee pain patterns in older adults with or at risk for knee osteoarthritis.
Curcuma longa decreased knee pain but did not affect knee effusion-synovitis or cartilage composition in knee osteoarthritis.
A pooled analysis evaluated reductions in migraine and headache days among patients with chronic migraine and comorbid depression in 2 placebo-controlled, phase 3 trials of fremanezumab.
Pregnancy and insurance status were significant barriers to obtaining appointments for opioid use disorder treatment.